Steadview Capital — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
Digitdigit.bioinMay 2024 · $141M
Digital Biology (Digit Bio) develops precision biologics and combination therapies for solid tumors, using its M×P (Molecules × Phenotypes) Platform that combines high-resolution imaging, next-generation sequencing, computation, and AI to map the spatial molecular organization of tumor tissues.
AI & Machine LearningBiotechDeep TechHealthtech
Co-investorsFifty YearsA91 PartnersGoldman SachsHSBCMorgan Stanley
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.